Élan Corporation plc is a major drugs firm based in Dublin, Ireland which has major interests in the United States.
The company was founded in Ireland by American businessman Don Panoz in 1969. In the late 1990s its value on the Irish Stock Exchange reached over €20bn. However, in 2002 an accounting scandal and investor reactions to the global slump, caused a major devaluation resulting in a share price slump of over 90%. Since then the company has regained its growth path under the reign of a new American CEO Kelly Martin. In July 2010, Élan was fined $203m for its marketing of epilepsy drugs.[1]
See Also
Loading...